Eli Lilly’s triple-agonist obesity drug retatrutide reduced body weight by up to 28% after 80 weeks of treatment in a phase 3 trial. The high-dose, 12 mg group recorded a 28% reduction, while the low-dose, 4 mg group recorded a 19% reduction. The discontinuation rate due to adver
2026-05-22
Amgen’s autoimmune disease treatment Tavneos will resume prescriptions for new patients in Japan after 20 deaths linked to serious liver injury were reported. Japanese partner Kissei Pharmaceutical discussed the matter with local health authorities and added a warning about serio
2026-05-22
RA Capital’s third special purpose acquisition company (SPAC) raised $75 million (approximately 108.7 billion won) through its Nasdaq listing. The SPAC issued 7.5 million shares at $10 each and is targeting a merger with a Chinese biotech company. RA Capital’s first SPAC previous
2026-05-22
Medtronic will acquire chronic pain treatment device company SPR Therapeutics for approximately 942.5 billion won. The company’s SPRINT system demonstrated at least 50% pain relief in more than 71% of patients. The SPRINT peripheral nerve stimulation (PNS) system is a minimally i
2026-05-22
Eli Lilly has sued mail-order pharmacies and others over alleged $200 million in rebate fraud involving the diabetes drug Trulicity. The defendants are accused of falsely claiming rebates as if they had dispensed the drug to patients, while actually reselling it to third-party wh
2026-05-22
Merck and Cullun Biotech’s lung cancer drug was found to reduce the risk of tumor progression by 65% in a phase 3 trial. The drug is being developed as a first-line treatment for advanced non-small cell lung cancer and combines an antibody-drug conjugate (ADC) with a PD-1 immune
2026-05-22
Exercise’s antidepressant effects appear to result from the action of the muscle protein apelin in the brain. Apelin activates CK2 and calpain-2 signaling in the hippocampus, and the effects of exercise disappeared in mice when it was removed. The findings suggest the possibility
2026-05-22
Samil Pharmaceutical has signed a memorandum of understanding with U.S.-based KC Pharmaceuticals for the distribution of ophthalmic drugs in North America. Founded in 1987, KC Pharmaceuticals is North America’s largest private-label ophthalmic drug manufacturer, and the companies
2026-05-22
Japanese researchers have developed nanoparticles that eliminated 100% of multidrug-resistant tumors and achieved a 100% survival rate. The particles first release a drug-pump inhibitor to neutralize resistance, followed by the sequential release of an anticancer drug to kill can
2026-05-22
Analysis of more than 12,000 wastewater samples found that the genetic diversity of viruses predicted COVID-19 surges more accurately than viral concentration. The metric can detect surges 2 to 5 days earlier than actual clinical reports and is less affected by environmental vari
2026-05-22
